Lazard Asset Management
BIO icon

Lazard Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Lazard Asset Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-18,290
Closed -$5.1M – 1963
2026
Q1 		$5.1M Buy
+18,290
New +$5.27M 0.01% 555
2025
Q1 		– Sell
-4
Closed -$1K – 2318
2024
Q4 		$1K Hold
4
– – ﹤0.01% 2205
2024
Q3 		$1K Hold
4
– – ﹤0.01% 2125
2024
Q2 		$1K Hold
4
– – ﹤0.01% 2127
2024
Q1 		$1K Hold
4
– – ﹤0.01% 1956
2023
Q4 		$1K Hold
4
– – ﹤0.01% 2186
2023
Q3 		$1K Hold
4
– – ﹤0.01% 2215
2023
Q2 		$1K Sell
4
-1
-20% -$407 ﹤0.01% 2245
2023
Q1 		$2K Hold
5
– – ﹤0.01% 2200
2022
Q4 		$2K Buy
5
+1
+25% +$404 ﹤0.01% 2281
2022
Q3 		$1K Hold
4
– – ﹤0.01% 2234
2022
Q2 		$1K Sell
4
-2,322
-100% -$1.21M ﹤0.01% 2309
2022
Q1 		$1.31M Sell
2,326
-5,008
-68% -$3.02M ﹤0.01% 962
2021
Q4 		$5.54M Sell
7,334
-1,875
-20% -$1.4M 0.01% 759
2021
Q3 		$6.87M Sell
9,209
-2,110
-19% -$1.58M 0.01% 689
2021
Q2 		$7.29M Buy
11,319
+11,077
+4,577% +$6.74M 0.01% 659
2021
Q1 		$138K Buy
242
+23
+11% +$13.6K ﹤0.01% 1154
2020
Q4 		$127K Sell
219
-341
-61% -$194K ﹤0.01% 1148
2020
Q3 		$287K Buy
560
+495
+762% +$251K ﹤0.01% 935
2020
Q2 		$29K Buy
65
+6
+10% +$2.65K ﹤0.01% 1376
2020
Q1 		$20K Buy
+59
New +$21.7K ﹤0.01% 1436
2019
Q2 		– Sell
-4,026
Closed -$1.23M – 1195
2019
Q1 		$1.23M Buy
+4,026
New +$1.09M ﹤0.01% 820

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Lazard Asset Management's BIO Position: Q2 2026 in Review

Lazard Asset Management sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2026, closing a stake of 18,290 shares — an estimated $5.1M sold.

Lazard Asset Management first reported a position in BIO in Q1 2019 and held it in 22 quarters. The position peaked at $7.29M in Q2 2021. 398 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Lazard Asset Management reported no remaining Bio-Rad Laboratories Class A position as of Q2 2026 after selling out during the quarter.
  • Lazard Asset Management sold 18,290 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $5.1M.
  • Lazard Asset Management first reported a position in Bio-Rad Laboratories Class A in Q1 2019 and held it in 22 quarters.
  • Lazard Asset Management's Bio-Rad Laboratories Class A position peaked at $7.29M in Q2 2021.
  • 398 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Lazard Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.